Write For Us

Bharat Biotech Enrols Over 25,000 Volunteers For Covaxin Phase 3 Trial

Sponsored Post Vitamin D2 Canada Persia
88 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

ava
Published
Bharat Biotech has enrolled 25,800 volunteers for phase 3 clinical trials of its COVID-19 vaccine, the company said today. The maker of Covaxin is one of the two firms cleared by the government to deploy their product for mass inoculation in the country. The other is Oxford-AstraZeneca's Covishield manufactured by the Serum Institute of India.

NDTV is one of the leaders in the production and broadcasting of un-biased and comprehensive news and entertainment programmes in India and abroad. NDTV delivers reliable information across all platforms: TV, Internet and Mobile.

Subscribe for more videos: https://www.youtube.com/user/ndtv?sub_confirmation=1
Like us on Facebook: https://www.facebook.com/ndtv
Follow us on Twitter: https://twitter.com/ndtv
Download the NDTV Apps: http://www.ndtv.com/page/apps
Watch more videos: http://www.ndtv.com/video?yt
Category
Asia
Tags
NDTV 24x7, Covid Vaccine, Coronavirus
Sign in or sign up to post comments.
Be the first to comment